Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 795 |
|
|||||
| News | - | ||||||
| Day High | 9.01 | Low High |
|||||
| Day Low | 8.91 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Talis Biomedical Corporation | TLIS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.085 | -0.94% | 8.91 | 15:07:10 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 9.01 | 8.91 | 9.01 | 8.91 | 8.995 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 27 | 795 | US$ 8.91 | US$ 7,083 | - | 4.35 - 9.60 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 3 | US$ 9.02 | USD |
Talis Biomedical Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 16.23M | 1.82M | - | 2.13M | -62.01M | -34.05 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Talis Biomedical News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/08/2024 | 07:04 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 1/26/2024 | 15:33 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/14/2023 | 07:00 | GlobeNewswire Inc. | Talis Biomedical Announces Exploration of Strategic.. |
| 9/01/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/10/2023 | 16:01 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 8/10/2023 | 15:46 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/10/2023 | 15:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/10/2023 | 15:05 | GlobeNewswire Inc. | Talis Biomedical Announces Second Quarter 2023 Financial.. |
| 8/03/2023 | 07:00 | GlobeNewswire Inc. | Talis Biomedical to Report Second Quarter 2023 Financial.. |
| 8/02/2023 | 07:18 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 8/02/2023 | 07:17 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of.. |
| 8/02/2023 | 07:15 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TLIS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.10 | 9.25 | 8.88 | 9.05 | 4,115 | -0.19 | -2.09% |
| 1 Month | 9.03 | 9.5299 | 8.68 | 9.01 | 5,758 | -0.12 | -1.33% |
| 3 Months | 9.23 | 9.60 | 7.5001 | 8.84 | 7,239 | -0.32 | -3.47% |
| 6 Months | 8.25 | 9.60 | 7.01 | 8.42 | 8,340 | 0.66 | 8.00% |
| 1 Year | 7.467 | 9.60 | 4.35 | 7.41 | 20,223 | 1.44 | 19.33% |
| 3 Years | 180.00 | 193.20 | 4.35 | 58.05 | 127,182 | -171.09 | -95.05% |
| 5 Years | 435.00 | 507.90 | 4.35 | 89.65 | 139,982 | -426.09 | -97.95% |
Talis Biomedical Description
| Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19. |
